首页> 外文期刊>Nature >SLC25A51 is a mammalian mitochondrial NAD~+ transporter
【24h】

SLC25A51 is a mammalian mitochondrial NAD~+ transporter

机译:SLC25A51是哺乳动物线粒体NAD〜+运输扣

获取原文
获取原文并翻译 | 示例
           

摘要

Mitochondria require nicotinamide adenine dinucleotide (NAD~(+)) to carry out the fundamental processes that fuel respiration and mediate cellular energy transduction. Mitochondrial NAD~(+)transporters have been identified in yeast and plants~(1,2), but their existence in mammals remains controversial~(3-5). Here we demonstrate that mammalian mitochondria can take up intact NAD~(+), and identify SLC25A51 (also known as MCART1)-an essential~(6,7)mitochondrial protein of previously unknown function-as a mammalian mitochondrial NAD~(+)transporter. Loss of SLC25A51 decreases mitochondrial-but not whole-cell-NAD~(+)content, impairs mitochondrial respiration, and blocks the uptake of NAD~(+)into isolated mitochondria. Conversely, overexpression of SLC25A51 or SLC25A52 (a nearly identical paralogue of SLC25A51) increases mitochondrial NAD~(+)levels and restores NAD~(+)uptake into yeast mitochondria lacking endogenous NAD~(+)transporters. Together, these findings identify SLC25A51 as a mammalian transporter capable of importing NAD~(+)into mitochondria.
机译:线粒体需要烟酰胺腺嘌呤二核苷酸(NAD〜(+))以进行燃料呼吸和介导细胞能量转导的根本过程。线粒体NAD〜(+)转运蛋白已在酵母和植物中鉴定〜(1,2),但它们在哺乳动物中的存在仍存在争议〜(3-5)。在这里,我们证明哺乳动物线粒体可以占用完整的NAD〜(+),并鉴定SLC25A51(也称为McART1)-an至必要的〜(6,7)线粒体蛋白质的先前未知的功能 - 作为哺乳动物线粒体NAD〜(+)运输车。 SLC25A51的丧失降低了线粒体 - 但不是全细胞 - NAD〜(+)含量,损害线粒体呼吸,并阻止NAD〜(+)的摄取到分离的线粒体中。相反,SLC25A51或SLC25A52的过度表达(SLC25A51的几乎相同的常例性)增加了线粒体NAD〜(+)水平并将NAD〜(+)摄取恢复到缺乏内源性NAD〜(+)转运蛋白的酵母线粒体中。这些发现一起鉴定了SLC25A51作为能够将NAD〜(+)导入线粒体的哺乳动物转运物。

著录项

  • 来源
    《Nature》 |2020年第7836期|174-179|共6页
  • 作者单位

    Department of Physiology and Institute for Diabetes Obesity and Metabolism Perelman School of Medicine University of Pennsylvania;

    Department of Molecular Biosciences University of Texas at Austin;

    Department of Molecular Biosciences University of Texas at Austin;

    Department of Biomedicine University of Bergen;

    Department of Chemical Biology Max Planck Institute for Medical Research|Faculty of Chemistry and Earth Sciences University of Heidelberg;

    Department of Physiology and Institute for Diabetes Obesity and Metabolism Perelman School of Medicine University of Pennsylvania;

    Department of Physiology and Institute for Diabetes Obesity and Metabolism Perelman School of Medicine University of Pennsylvania;

    Department of Molecular Biosciences University of Texas at Austin;

    Lewis-Sigler Institute for Integrative Genomics Department of Chemistry Princeton University;

    Lewis-Sigler Institute for Integrative Genomics Department of Chemistry Princeton University;

    Mitchell Cancer Institute University of South Alabama;

    Lewis-Sigler Institute for Integrative Genomics Department of Chemistry Princeton University;

    Department of Pathology and Laboratory Medicine Perlman School of Medicine University of Pennsylvania;

    Department of Chemical Biology Max Planck Institute for Medical Research|Institute of Chemical Sciences and Engineering École Polytechnique Fédérale de Lausanne (EPFL);

    Department of Biomedicine University of Bergen;

    Department of Molecular Biosciences University of Texas at Austin;

    Department of Physiology and Institute for Diabetes Obesity and Metabolism Perelman School of Medicine University of Pennsylvania;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号